Differentiation of metastatic vs degenerative joint disease using semi-quantitative analysis with (18)F-NaF PET/CT in castrate resistant prostate cancer patients.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  American Journal of Nuclear Medicine and Molecular Imaging

• Publication date

  2015-01-15

• Fields of study

  Medicine

• Identifiers
  PMID 25973337PMCID PMC4396008
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diseases

  2021cited by this paper
• Imaging in Oncology

  2017cited by this paper
• Musculoskeletal imaging using fluoride PET.

  2013cited by this paper
• Pilot Prospective Evaluation of 99mTc-MDP Scintigraphy, 18F NaF PET/CT, 18F FDG PET/CT and Whole-Body MRI for Detection of Skeletal Metastases

  2013cited by this paper
• Bone metabolism of residual ridge beneath the denture base of an RPD observed using NaF-PET/CT.

  2012cited by this paper
• Precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism

  2012cited by this paper
• Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases.

  2012cited by this paper
• 18F-fluoride PET: changes in uptake as a method to assess response in bone metastases from castrate-resistant prostate cancer patients treated with 223Ra-chloride (Alpharadin)

  2011cited by this paper
• SUV: From Silly Useless Value to Smart Uptake Value

  2010cited by this paper
• Metastatic Spinal Lesions: State-of-the-Art Treatment Options and Future Trends

  2008cited by this paper
• Increased 18F-FDG uptake in degenerative disease of the spine: Characterization with 18F-FDG PET/CT.

  2006cited by this paper
• Positron emission tomography as an imaging biomarker.

  2006cited by this paper
• The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.

  2006cited by this paper
• Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities.

  2005cited by this paper
• Assessment of malignant skeletal disease: initial experience with 18F-fluoride PET/CT and comparison between 18F-fluoride PET and 18F-fluoride PET/CT.

  2004cited by this paper
• Bone imaging in metastatic breast cancer.

  2004cited by this paper
• Prospective evaluation of the clinical value of planar bone scans, SPECT, and (18)F-labeled NaF PET in newly diagnosed lung cancer.

  2001cited by this paper
• Radiological imaging for the diagnosis of bone metastases.

  2001cited by this paper
• FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions.

  2001cited by this paper
• Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate.

  2001cited by this paper
• The role of positron emission tomography in the management of bone metastases

  2000cited by this paper
• Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET.

  1999cited by this paper
• Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography.

  1999cited by this paper
• Bone scanning in clinical oncology: does it have a future?

  1998cited by this paper
• Oncologic imaging: interactions of nuclear medicine with CT and MRI using the bone scan as a model.

  1997cited by this paper
• Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET.

  1997cited by this paper
• SUV: standard uptake or silly useless value?

  1995cited by this paper
• Role of SPECT in differentiating malignant from benign lesions in the lower thoracic and lumbar vertebrae.

  1993cited by this paper
• Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET.

  1992cited by this paper
• Fluorine-18: a new isotope for bone scanning.

  1962cited by this paper

• Superiority of 68Ga-DOTA-FAPI-04 PET/CT to 18F-FDG PET/CT in the evaluation of different cancers with bone metastases.

  2025cites this paper
• Correlation between the maximum standard uptake value and mean Hounsfield unit on single-photon emission computed tomography-computed tomography to discriminate benign and metastatic lesions among patients with breast cancer

  2024cites this paper
• Feasibility of Global Assessment of Bone Metastases in Prostate Cancer with 18F-Sodium Fluoride-PET/Computed Tomography.

  2022cites this paper
• 68Ga-P15-041, A Novel Bone Imaging Agent for Diagnosis of Bone Metastases

  2021cites this paper
• Standardized Uptake Value from Semiquantitative Bone Single-Photon Emission Computed Tomography/Computed Tomography in Normal Thoracic and Lumbar Vertebrae of Breast Cancer Patients

  2020cites this paper
• Molecular Imaging of Prostate Cancer

  2020cites this paper
• Prostate MRI Essentials: A Practical Guide for Radiologists

  2020cites this paper
• Clinical value of dual-phase F-18 sodium fluoride PET/CT for diagnosing bone metastasis in cancer patients with solitary bone lesion.

  2020cites this paper
• Maximum standardized uptake value from quantitative bone single-photon emission computed tomography/computed tomography in differentiating metastatic and degenerative joint disease of the spine in prostate cancer patients

  2019cites this paper
• Skeletal Metastasis Evaluation: Value and Impact of PET/Computed Tomography on Diagnosis, Management and Prognosis.

  2019cites this paper
• Molecular imaging of bone metastases using tumor-targeted tracers.

  2019cites this paper
• 18F-Sodium fluoride positron emission tomography: History, technical feasibility, mechanism of action, normal bio-distribution, and diagnostic performance in bone metastasis detection compared to other imaging modalities.

  2019cites this paper
• 18F-NaF PET/CT imaging versus 99mTc-MDP scintigraphy in assessing metastatic bone disease in patients with prostate cancer

  2019cites this paper
• Automated classification of benign and malignant lesions in 18F-NaF PET/CT images using machine learning

  2018cites this paper
• Targeted α-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicine.

  2018cites this paper
• Skeletal Metastases and Benign Mimics on NaF PET/CT: A Pictorial Review.

  2018cites this paper
• Nuclear Medicine (Bone Scan, Choline and PSMA PET/CT)

  2017cites this paper
• The value of quantitative analysis in 18F-NaF PET/CT.

  2017cites this paper
• The use of PET/CT in prostate cancer

  2017cites this paper
• Clinical PET Imaging in Prostate Cancer.

  2017cites this paper
• Skeletal standardized uptake values obtained by quantitative SPECT/CT as an osteoblastic biomarker for the discrimination of active bone metastasis in prostate cancer

  2017influential citation
• Quantitative Assessment of Early [18F]Sodium Fluoride Positron Emission Tomography/Computed Tomography Response to Treatment in Men With Metastatic Prostate Cancer to Bone.

  2017cites this paper
• Therapy assessment of bone metastatic disease in the era of 223radium

  2017cites this paper
• A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [18F]FMAU-Positron Emission Tomography Imaging of Bone Metastases in Prostate Cancer

  2017cites this paper
• Quantitative analysis of 18F-NaF dynamic PET/CT cannot differentiate malignant from benign lesions in multiple myeloma.

  2017cites this paper
• Nuclear Medicine Modalities to Image Bone Metastases with Bone-Targeting Agents: Conventional Scintigraphy and Positron-Emission Tomography

  2017cites this paper
• Primärstaging des Prostatakarzinoms

  2017cites this paper
• Diagnostic Applications of Nuclear Medicine: Prostatic Cancer

  2016cites this paper
• PET Imaging of Skeletal Metastases and Its Role in Personalizing Further Management.

  2016cites this paper
• 18F-NaF-PET/CT and 99mTc-MDP Bone Scintigraphy in the Detection of Bone Metastases in Prostate Cancer.

  2016cites this paper
• Repeatability of Quantitative 18F-NaF PET: A Multicenter Study

  2016cites this paper
• Contemporary approaches for imaging skeletal metastasis

  2015cites this paper